Activation of an adaptive antitumor immune response by the polymeric fluoropyrimidine CF10 involves TS/Top1 dual targeting - 21/05/26
Abstract |
5-Fluorouracil (5-FU)-based regimens remain the backbone of therapy for metastatic colorectal cancer (mCRC), yet durable responses are rare.CF10, a next-generation polymeric fluoropyrimidine, has demonstrated superior antitumor activity compared with 5-FU in preclinical models. Here, we evaluated whether CF10 more effectively induces immunogenic cell death (ICD) and promotes antitumor immunity, while characterizing its dual mechanism involving thymidylate synthase (TS) inhibition and replication stress through Topoisomerase 1 cleavage complex (Top1cc) stabilization and γ-H2AX accumulation. In murine (MC38) and human (HCT116) colorectal cancer cells, CF10 induced significantly higher levels of ICD markers—extracellular ATP, HMGB1 release, and surface calreticulin—than 5-FU and triggered robust Top1cc stabilization with γ-H2AX foci formation. Conditioned media from CF10-treated cells enhanced dendritic cell (DC) maturation and secretion of TNF-α, IL-1β, CCL2, and CCL4. In vivo, CF10 treatment in C57BL/6 mice bearing orthotopic MC38 liver metastases increased CD4⁺, CD8⁺, and γδ T-cell infiltration, reduced myeloid-derived suppressor cells (MDSCs), and decreased hepatic tumor burden. CF10 also decreased FoxP3⁺ regulatory T cells and CD206⁺ immunosuppressive macrophages. DC vaccination using CF10-conditioned supernatants modestly extended survival and increased tumor-infiltrating T cells compared with 5-FU or untreated controls. CF10 elicits a dual-action mechanism—cytotoxicity via TS inhibition and Top1cc-dependent replication stress (γ-H2AX) and immunogenicity through ICD induction—driving potent DC activation and adaptive immune responses. These findings position CF10 as a promising immunomodulatory chemotherapeutic for mCRC and support clinical evaluation, including combination strategies with immune checkpoint blockade.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | CF10 induces stronger immunogenic cell death than 5-FU in colorectal cancer models. |
• | Dual mechanism: TS inhibition and Top1cc-dependent replication stress (γ-H2AX). |
• | CF10-conditioned media promotes dendritic cell maturation and cytokine secretion. |
• | CF10 promotes antitumor immunity by increasing effector T cells while diminishing MDSCs. |
• | CF10 shows immunomodulatory potential, supporting combination with checkpoint blockade. |
Abbreviations : 5-FU , mCRC , CF10 , ICD , eATP , HMGB1 , CRT , DC , BMDC , TS , Top1 , DAMPs , ICB , FOLFOX , FOLFIRI , MDSC , PBMC , LPS , IL , TNF-α , CCL , MCP-1 , MIP-1α/β , RANTES , qRT-PCR , PBS , FBS , MEM , DMEM , IVIS , OCT , H&E , MFI , CTR , Sup , RRID
Keywords : Immunogenic cell death (ICD), Dendritic cell maturation, CF10, 5-fluorouracil (5-FU), Colorectal cancer, Antitumor immunity
Plan
Vol 199
Article 119399- juin 2026 Retour au numéro
Article précédent
- Early-stage antidiabetic potential of hemp seed hull-derived Cannabisins A, B, and F: Integrated computational and experimental evidence for intestinal α-glucosidase inhibition and incretin modulation
- Sang Seop Lee, Jang Hoon Kim, Sang Hoon Lee, So Yeon Kim, Kyong Hwan Bang, Yung Choon Yoo
- Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt
- Eetu Valkama, Elisa Toropainen, Simar Pal Singh, Annika Valtari, Ali Koskela, Arto Merivaara, Oswaldo Perez, Marika Ruponen, John Groten, Nicolaas Schipper, Arto Urtti, Kati-Sisko Vellonen, Tatu Lajunen, Jooseppi Puranen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?